This content is machine translated Cardiovascular Risk in Rheumatoid Arthritis What is the most dangerous thing for RA? Persistent disease activity and cumulative inflammation in rheumatoid arthritis (RA) are associated with the progression of atherosclerosis and cardiovascular events, whereas effective inflammation control is associated with lower event rates....…
View Post 14 min This content is machine translated Fibromyalgia Syndrome Development, Diagnosis, Epidemiology, and Treatment of a Disease Entity According to the 2010 and 2011 ACR diagnostic criteria, as revised in 2016, fibromyalgia syndrome is a multisymptomatic disorder whose primary symptom is chronic tendon-muscle pain that shifts and spreads...… CME-Test
View Post 7 min This content is machine translated Juvenile Idiopathic Arthritis Early Detection and Targeted Treatment in an Interdisciplinary Setting Juvenile idiopathic arthritis is the most common autoimmune disease in childhood—the incidence among children under 16 is approximately 1 in 1,000. Early diagnosis and appropriate treatment remain a challenge. As...…
View Post 6 min This content is machine translated Innovative Oral Treatment Options for Psoriasis: Icotrokinra and Zasocitinib First-class immunomodulation combined with convenience—the data available so far is convincing Our understanding of the pathophysiology of psoriasis has improved significantly in recent years, and numerous therapeutic targets have been identified. This has recently led to the development of innovative active...…
View Post 14 min This content is machine translated Fibromyalgia Syndrome Development, Diagnosis, Epidemiology, and Treatment of a Disease Entity According to the 2010 and 2011 ACR diagnostic criteria, as revised in 2016, fibromyalgia syndrome is a multisymptomatic disorder whose primary symptom is chronic tendon-muscle pain that shifts and spreads...… CME-Test
View Post 5 min This content is machine translated Clinically Suspected Arthralgias “Watchful waiting” or intervention? The pathogenesis of rheumatoid arthritis (RA) begins years before clinical manifestation, but not all patients with joint pain develop RA. Since the primary care physician or internist’s office is usually...…
View Post 5 min This content is machine translated Systemic Lupus (SLE): What Does the Diagnosis and Treatment Toolbox Have to Offer? Treat-to-Target – Consensus Recommendations for GC Tapering and the Use of DMARDs In addition to the EULAR (European Alliance of Associations for Rheumatology)/ACR (American College of Rheumatology) classification criteria, there are other validated tools that facilitate the early detection of SLE, such...…
View Post 6 min This content is machine translated PMR and LVV: Current EULAR Recommendations Polymyalgia rheumatica, giant cell arteritis, and Takayasu arteritis Giant cell arteritis and Takayasu arteritis are inflammatory conditions affecting the aorta and/or its branch vessels, also known collectively as “large vessel vasculitis ” (LVV ). Polymyalgia rheumatica is an...…
View Post 5 min This content is machine translated Case study Discoid Lupus Erythematosus in a 38-Year-Old Woman Discoid lupus erythematosus (DLE) accounts for 50–80% of all cases of chronic cutaneous lupus, making it the most common subtype. The diagnosis is primarily clinical but is supported by histopathology...…
View Post 3 min This content is machine translated Psoriasis Research: What's in the Pipeline? Highly selective oral TYK inhibitors in Phase III Envudeucitinib and Zasocitinib are oral, allosteric tyrosine kinase 2 (TYK2) inhibitors currently being evaluated in clinical trials for plaque psoriasis. The interim results presented during the Late-Breaking Research sessions at...…
View Post 5 min This content is machine translated Psoriasis in the Age of Precision Medicine Systemic Therapy for Patients with Comorbidities: What Is the Best Choice? Psoriasis is a chronic inflammatory systemic disease often associated with comorbidities, a fact that must be taken into account during treatment. Particular attention should be paid to psoriatic arthritis (PsA),...…
